Zions director awarded 2,055 ZION shares
Contreras-Sweet Maria reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Contreras-Sweet Maria reported acquisition or exercise transactions in this Form 4 filing.
Zions Bancorporation director Maria Contreras-Sweet received a stock grant of 2,055 common shares of ZION on May 1, 2026. The shares were awarded at $63.26 per share as compensation, not as an open-market purchase. After this award, she directly holds 15,877 common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,055 | $63.26 | $130K |
Key Figures
Key Terms
Form 4 regulatory
Grant, award, or other acquisition financial
non-derivative financial
transaction code A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Zions Bancorporation (ZION) director Maria Contreras-Sweet report on this Form 4?
Was the ZION Form 4 transaction a stock purchase or a compensation grant?
Does the ZION Form 4 show any stock sales or derivative exercises by the director?
AI-generated analysis. How Rhea-AI works. Not financial advice.